デフォルト表紙
市場調査レポート
商品コード
1676626

整形外科用細胞治療の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore

Orthopedic Cell Therapy Market Size, Share, and Trend Analysis | Global | 2025-2031 | MedCore | Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market

出版日
ページ情報
英文 75 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.38円
整形外科用細胞治療の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore
出版日: 2025年01月24日
発行: iData Research Inc.
ページ情報: 英文 75 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

世界の整形外科用細胞治療の市場規模は、2024年に5億5,130万米ドルとなりました。同市場は、7.2％のCAGRで拡大し、2031年には8億9,580万米ドルに達すると予測されています。

COVID-19の流行により、選択的手術の延期により一時的に売上が減少しました。 しかし、2022年までに市場は回復し、安定成長の軌道に戻るとみられています。

再生医療の成長により、多血小板血漿（PRP）や骨髄吸引液（BMA）療法の需要が高まっています。処理システムの改善により、整形外科用細胞療法の有効性と採用が強化されています。

当レポートでは、世界の整形外科用細胞治療市場について調査し、市場の概要とともに、市場分析と予測、促進要因と抑制要因、競合情勢などを提供しています。

目次

エグゼクティブサマリー

  • 世界の整形外科用細胞治療市場概要
  • 競合分析
  • 市場セグメンテーション
  • 対象地域

イントロダクション

  • 多血小板血漿
  • 濃縮骨髄穿刺液

手技件数

  • 総合整形外科細胞治療
  • 多血小板血漿法
  • 骨髄穿刺濃縮治療

市場概要

  • セグメント別
  • 地域別

市場分析と予測

  • 多血小板血漿市場
  • 骨髄穿刺濃縮液市場

件数分析

  • 多血小板血漿
  • 骨髄穿刺濃縮物

促進要因と抑制要因

競合市場シェア分析

図表

LIST OF CHARTS

  • Chart 6 1: Orthopedic Cell Therapy Market, Global, 2024 & 2031
  • Chart 6 2: Orthopedic Cell Therapy Procedures, Global, 2024
  • Chart 6 3: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Chart 6 4: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031
  • Chart 6 5: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031
  • Chart 6 6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024

LIST OF FIGURES

  • Figure 6 1: Orthopedic Cell Therapy Procedure Segmentation
  • Figure 6 2: Orthopedic Cell Therapy Market Segmentation
  • Figure 6 3: Orthopedic Cell Therapy Regions Covered, Global (1 of 2)
  • Figure 6 4: Orthopedic Cell Therapy Regions Covered, Global (2 of 2)
  • Figure 6 5: Orthopedic Cell Therapy Procedures by Segment, Global, 2021 - 2031
  • Figure 6 6: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Figure 6 7: Orthopedic Cell Therapy Procedures by Country, North America, 2021- 2031
  • Figure 6 8: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 9: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 10: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 11: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 12: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 13: Orthopedic Cell Therapy Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 14: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 15: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 16: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 17: Orthopedic Cell Therapy Procedures by Country, Africa, 2021 - 2031
  • Figure 6 18: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2021 - 2031
  • Figure 6 19: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2021 - 2031
  • Figure 6 20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 26: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 27: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 28: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 29: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2021 - 2031
  • Figure 6 30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2021 - 2031
  • Figure 6 31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2021 - 2031
  • Figure 6 32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 38: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 39: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 40: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 41: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2021 - 2031
  • Figure 6 42: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 6 43: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 6 44: Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6 45: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6 46: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$)
  • Figure 6 47: Market Value by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$M)
  • Figure 6 48: Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6 49: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6 50: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$)
  • Figure 6 51: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$M)
  • Figure 6 52: Platelet-Rich Plasma Units Sold by Indication, Global, 2021 - 2031
  • Figure 6 53: Bone Marrow Aspirate Concentrate Units Sold by Indication, Global, 2021 - 2031
  • Figure 6 54: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024
目次
Product Code: iDATA_GLOB25_MC_OCT

The global orthopedic cell therapy market was valued at $551.3 million in 2024 and is projected to grow at a CAGR of 7.2%, reaching $895.8 million by 2031.

This market includes two primary therapy types:

  • Platelet-Rich Cell Therapy
  • Bone Marrow Cell Therapy
  • Market Insights & Data Coverage
  • Unit Sales & Average Selling Prices
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Historical Data (2021-2023)
  • Competitive Landscape, Mergers & Acquisitions
  • Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

  • The COVID-19 pandemic caused a temporary decline in sales due to the postponement of elective procedures.

* By 2022, the market rebounded, returning to a trajectory of steady growth.

* Advancements in Cell Therapy Technology:

  • Growth in regenerative medicine is driving demand for platelet-rich plasma (PRP) and bone marrow aspirate (BMA) therapies.

* Improved processing systems are enhancing the efficacy and adoption of orthopedic cell therapies.

  • Increased Adoption in Orthopedics & Sports Medicine:

* Rising demand for minimally invasive treatments is fueling the market.

* Soft tissue injuries, joint reconstructions, and spine treatments are key growth areas.

Market Share Insights

Top Competitors in the Global Orthopedic Cell Therapy Market (2024):

1 Terumo

* Market leader with its Harvest Technologies division.

* Offers Harvest(R) BMAC, Harvest(R) PRP, and the Harvest(R) AdiPrep(R) adipose tissue concentrator.

* The Harvest(R) SmartPrep system enables multicellular processing for bone marrow, blood, and adipose tissue.

2 Zimmer Biomet

* Second-largest market share with its Plasmax(R) Plasma concentration system and BioCUE(TM) System.

* BioCUE(TM) System processes both bone marrow and whole blood for cell therapy applications.

3 Arthrex

* Third-largest competitor, known for its Angel(R) cPRP and Bone Marrow Processing System.

* The Angel(R) System automates the separation and concentration of PRP and BMA for orthopedic and soft tissue applications.

Market Segmentation Summary

  • Platelet-Rich Cell Therapy Market

* Indications: Soft Tissue, Spine, Cardiac, Orthopedic, Plastics.

  • Bone Marrow Cell Therapy Market

* Indications: Soft Tissue, Spine, Trauma, Joint Reconstructions.

Global Research Scope

  • Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage

  • Market Size, Market Shares
  • Market Forecasts, Growth Rates
  • Units Sold, Average Selling Prices
  • Procedure Numbers

Qualitative Coverage

  • COVID-19 Impact
  • Market Growth Trends & Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles & Product Portfolios
  • FDA Recalls, Disruptive Technologies
  • Disease Overviews

Data Sources:

  • Primary Interviews with Industry Leaders
  • Government Physician Data & Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

  • 6.1 EXECUTIVE SUMMARY
    • 6.1.1 Global Orthopedic Cell Therapy Market Overview
    • 6.1.2 Competitive Analysis
    • 6.1.3 Procedure Segmentation
    • 6.1.4 Market Segmentation
    • 6.1.5 Regions Included
  • 6.2 INTRODUCTION
    • 6.2.1 Platelet-Rich Plasma
    • 6.2.2 Concentrated Bone Marrow Aspirate
  • 6.3 PROCEDURE NUMBERS
    • 6.3.1 Total Orthopedic Cell Therapy Procedures
    • 6.3.2 Platelet-Rich Plasma Procedures
    • 6.3.3 Bone Marrow Aspirate Concentrate Procedures
  • 6.4 MARKET OVERVIEW
    • 6.4.1 By Segment
    • 6.4.2 By Region
  • 6.5 MARKET ANALYSIS AND FORECAST
    • 6.5.1 Platelet-Rich Plasma Market
    • 6.5.2 Bone Marrow Aspirate Concentrate Market
  • 6.6 UNIT ANALYSIS
    • 6.6.1 Platelet-Rich Plasma Unit Analysis
      • 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
    • 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
      • 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
  • 6.7 DRIVERS AND LIMITERS
    • 6.7.1 Market Drivers
    • 6.7.2 Market Limiters
  • 6.8 COMPETITIVE MARKET SHARE ANALYSIS